PDIA2 and colitis: In vivo, administration of 4‐PBA in an azoxymethane/dextran sulfate sodium (AOM/DSS) mouse model of colitis‐associated colorectal cancer led to the suppression of PDIA2 overexpression, restoration of metabolic homeostasis, and a marked reduction in tumor burden [41].